Longxin Wang Selected Research

Longxin Wang Research Topics

8	Neoplasms (Cancer) 01/2018 - 11/2008
7	Renal Cell Carcinoma (Grawitz Tumor) 01/2017 - 11/2008
3	Neoplasm Metastasis (Metastasis) 01/2017 - 11/2008
3	Carcinoma (Carcinomatosis) 01/2015 - 07/2014
2	Reperfusion Injury 10/2021 - 12/2020
2	Multiple Sclerosis 03/2021 - 12/2014
2	Carcinogenesis 01/2018 - 01/2015
1	Chronic Hepatitis B 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Chronic Pancreatitis 01/2020
1	Renal Insufficiency (Renal Failure) 01/2020
1	Exocrine Pancreatic Insufficiency 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	End Stage Liver Disease 01/2020
1	Non-Muscle Invasive Bladder Neoplasms 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 03/2016
1	Urinary Bladder Neoplasms (Bladder Cancer) 07/2014
1	Wound Infection (Wound Infections) 03/2009
1	Pathologic Constriction (Stenosis) 03/2009

3	Erythropoietin FDA Link 10/2021 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2014
2	Interleukin-17 (Interleukin 17)IBA 03/2021 - 12/2014
2	NF-kappa B (NF-kB)IBA 03/2021 - 12/2014
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015 - 01/2014
2	Transforming Growth Factor-beta Type II ReceptorIBA 01/2010 - 11/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2010 - 11/2008
1	Insulin (Novolin)FDA Link 01/2020
1	CateninsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	EphA4 ReceptorIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Tyrosine (L-Tyrosine)FDA Link 01/2017
1	EphA1 Receptor (Eph Receptor)IBA 01/2017
1	GlucuronidaseIBA 03/2016
1	AntigensIBA 03/2016
1	N- (4- doxorubicin- N- carbonyl(oxymethyl)phenyl)- O- glucuronyl carbamateIBA 03/2016
1	ProdrugsIBA 03/2016
1	EphA2 ReceptorIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Long Noncoding RNAIBA 07/2014
1	Biological ProductsIBA 07/2014
1	Messenger RNA (mRNA)IBA 07/2014
1	RNA (Ribonucleic Acid)IBA 07/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Fatty Acids (Saturated Fatty Acids)IBA 07/2013
1	alpha-Linolenic Acid (Linolenic Acid)IBA 07/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2013
1	Immunosuppressive Agents (Immunosuppressants)IBA 11/2008
1	VaccinesIBA 11/2008

2	Therapeutics 01/2018 - 03/2016
1	Transplantation 10/2021
1	Organ Transplantation 01/2020
1	Operative Surgical Procedures 01/2020
1	Kidney Transplantation 01/2020
1	Aftercare (After-Treatment) 03/2016
1	Intravenous Injections 03/2016
1	Immunotherapy 01/2010
1	Length of Stay 03/2009